RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of TLIS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Talis Biomedical Corporation stock price down 1.41% on Thursday
(Updated on Mar 28, 2024)

Buy or Hold candidate since Feb 13, 2024 Gain 10.20% PDF

The Talis Biomedical Corporation stock price fell by -1.41% on the last day (Thursday, 28th Mar 2024) from $8.88 to $8.75. During the last trading day the stock fluctuated 2.51% from a day low at $8.75 to a day high of $8.97. The price has been going up and down for this period, and there has been a -0.57% loss for the last 2 weeks. Volume has increased on the last day by 395 shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 4 thousand shares were bought and sold for approximately $31.86 thousand.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 13.67% during the next 3 months and, with a 90% probability hold a price between $8.94 and $10.68 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

TLIS Signals & Forecast

The Talis Biomedical Corporation stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $9.00. On a fall, the stock will find some support from the long-term average at approximately $8.50. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, March 18, 2024, and so far it has fallen -5.41%. Further fall is indicated until a new bottom pivot has been found. Talis Biomedical Corporation gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Talis Biomedical Corporation stock

Talis Biomedical Corporation finds support from accumulated volume at $8.64 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.220 between high and low, or 2.51%. For the last week, the stock has had daily average volatility of 1.75%.

Our recommended stop-loss: $8.41 (-3.94%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 8 days ago.)

Trading Expectations (TLIS) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Talis Biomedical Corporation to open at $8.82, and during the day (based on 14 day Average True Range), to move between $8.42 and $9.08, which gives a possible trading interval of +/-$0.325 (+/-3.72%) up or down from last closing price. If Talis Biomedical Corporation takes out the full calculated possible swing range there will be an estimated 7.43% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $8.64 (1.26%) than the resistance at $9.10 (4.00%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Talis Biomedical Corporation stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Talis Biomedical Corporation stock to perform well in the short-term.

Current score: 2.170 Buy Candidate Unchanged

Predicted Opening Price for Talis Biomedical Corporation of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$8.82 ( 0.84%) $8.75

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TLIS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 9.04 3.35 %
R2 8.96 2.39 %
R1 8.91 1.80 %
Current price: 8.75
Support S1 8.74 -0.122 %
S2 8.69 -0.716 %
S3 8.60 -1.68 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 9.20 5.14 %
R2 9.17 4.80 %
R1 9.10 4.00 %
Current price 8.75
Support S1 8.64 -1.26%
S2 7.94 -9.26%
S3 7.82 -10.63%

FAQ

What is the symbol for Talis Biomedical Corporation Stock and on which exchange is it traded?
The symbol for Talis Biomedical Corporation is TLIS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Talis Biomedical Corporation Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Talis Biomedical Corporation stock to perform well in the short-term.

How to buy Talis Biomedical Corporation Stock?
Talis Biomedical Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Talis Biomedical Corporation Stock.

What's the current price of Talis Biomedical Corporation Stock?
As of the end of day on the 2024-03-28, the price of an Talis Biomedical Corporation (TLIS) share was $8.75.

What is the 52-week high and low for Talis Biomedical Corporation Stock?
The 52-week high for Talis Biomedical Corporation Stock is $9.32 and the 52-week low is $0.432.

What is the market capitalization of Talis Biomedical Corporation Stock?
As of the 2024-03-28, the market capitalization of Talis Biomedical Corporation is 15.917M.

When is the next earnings date for Talis Biomedical Corporation?
The upcoming earnings date for Talis Biomedical Corporation is May 09, 2024.
Click to get the best stock tips daily for free!

About Talis Biomedical Corporation

Talis Biomedical Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's ... TLIS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT